JPWO2020047325A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020047325A5 JPWO2020047325A5 JP2021511582A JP2021511582A JPWO2020047325A5 JP WO2020047325 A5 JPWO2020047325 A5 JP WO2020047325A5 JP 2021511582 A JP2021511582 A JP 2021511582A JP 2021511582 A JP2021511582 A JP 2021511582A JP WO2020047325 A5 JPWO2020047325 A5 JP WO2020047325A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- cancer
- binding
- pharmaceutical composition
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724592P | 2018-08-29 | 2018-08-29 | |
| US62/724,592 | 2018-08-29 | ||
| US201862734948P | 2018-09-21 | 2018-09-21 | |
| US62/734,948 | 2018-09-21 | ||
| US201962823994P | 2019-03-26 | 2019-03-26 | |
| US62/823,994 | 2019-03-26 | ||
| PCT/US2019/048919 WO2020047325A1 (en) | 2018-08-29 | 2019-08-29 | Combination therapies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512539A JP2022512539A (ja) | 2022-02-07 |
| JPWO2020047325A5 true JPWO2020047325A5 (https=) | 2022-09-06 |
| JP2022512539A5 JP2022512539A5 (https=) | 2022-09-06 |
Family
ID=69644804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511582A Pending JP2022512539A (ja) | 2018-08-29 | 2019-08-29 | 併用療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210324041A1 (https=) |
| EP (1) | EP3844177A4 (https=) |
| JP (1) | JP2022512539A (https=) |
| KR (1) | KR20210068432A (https=) |
| CN (1) | CN112912384A (https=) |
| AU (1) | AU2019333173A1 (https=) |
| BR (1) | BR112021003683A2 (https=) |
| CA (1) | CA3109401A1 (https=) |
| CO (1) | CO2021003136A2 (https=) |
| MX (1) | MX2021002286A (https=) |
| WO (1) | WO2020047325A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240141014A1 (en) * | 2021-03-03 | 2024-05-02 | Shattuck Labs, Inc. | Mutant pd-1 extracellular domains |
| WO2022212845A2 (en) * | 2021-04-01 | 2022-10-06 | Shattuck Labs, Inc. | Pd-1- and ox40l-based chimeric proteins |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010062401A2 (en) * | 2008-11-26 | 2010-06-03 | Five Prime Therapeutics, Inc. | Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules |
| RU2766200C1 (ru) * | 2015-10-01 | 2022-02-09 | Хит Байолоджикс, Инк. | Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков |
| MX2019009812A (es) * | 2017-02-27 | 2019-10-14 | Shattuck Labs Inc | Proteinas quimericas basadas en tigit y light. |
-
2019
- 2019-08-29 JP JP2021511582A patent/JP2022512539A/ja active Pending
- 2019-08-29 BR BR112021003683-0A patent/BR112021003683A2/pt not_active Application Discontinuation
- 2019-08-29 CN CN201980068156.4A patent/CN112912384A/zh active Pending
- 2019-08-29 KR KR1020217009193A patent/KR20210068432A/ko not_active Withdrawn
- 2019-08-29 US US17/265,026 patent/US20210324041A1/en not_active Abandoned
- 2019-08-29 WO PCT/US2019/048919 patent/WO2020047325A1/en not_active Ceased
- 2019-08-29 MX MX2021002286A patent/MX2021002286A/es unknown
- 2019-08-29 AU AU2019333173A patent/AU2019333173A1/en not_active Abandoned
- 2019-08-29 CA CA3109401A patent/CA3109401A1/en active Pending
- 2019-08-29 EP EP19855957.7A patent/EP3844177A4/en not_active Withdrawn
-
2021
- 2021-03-10 CO CONC2021/0003136A patent/CO2021003136A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512541A5 (https=) | ||
| JP2022511286A5 (https=) | ||
| JP2021183650A (ja) | 治療用組成物、組合せ物および使用の方法 | |
| JP2020530298A5 (https=) | ||
| JP7102670B2 (ja) | 抗ｐｄ‐ｌ１抗体とｉｌ‐７との融合 | |
| EP4043492A1 (en) | Antibodies specific to human poliovirus receptor (pvr) | |
| FI3313441T3 (fi) | Kiinteiden kasvainten immunomodulaatio ja hoito spesifisesti cd38:aa sitovilla vasta-aineilla | |
| RS62935B1 (sr) | Primena riluzola, prolekova riluzola ili analoga riluzola sa imunoterapijama za lečenje kancera | |
| KR102088469B1 (ko) | Mek 억제제 및 igf1r 억제제의 병용 요법 | |
| US20220411512A1 (en) | Combination treatment for cancer | |
| US20220235134A1 (en) | Anti-b7-h3 antibodies | |
| EP3582811B1 (en) | Dosing schedule of a wnt inhibitor and an anti-pd-1 antibody molecule in combination | |
| CN113045655A (zh) | 抗ox40抗体及其用途 | |
| WO2022218383A1 (zh) | 抗体在抗肿瘤治疗中的用途 | |
| CN115724986B (zh) | 三特异性抗体及其用途 | |
| JP2022512539A5 (https=) | ||
| JPWO2020047328A5 (https=) | ||
| WO2024078479A1 (zh) | 一种异源二聚体融合蛋白及其应用 | |
| JPWO2020047319A5 (https=) | ||
| CN114616251A (zh) | 靶向PD-1和TGFβ的重组蛋白 | |
| JPWO2020047325A5 (https=) | ||
| CN111867598A (zh) | 肿瘤免疫赋活剂 | |
| JP2021500320A (ja) | 癌の治療のための配合剤 | |
| Banerjee et al. | Monoclonal antibodies for targeted therapy in colorectal cancer. | |
| JP2022503621A5 (https=) |